The Foundation for Government Accountability v. Department of Health and Human Services et al.

Why this Matters:

The plaintiff challenges federal guidance providing for non-enforcement of price transparency regulations requiring health insurers to disclose internal pricing data and negotiated rates in a machine-readable format (including prescription drug pricing data)—arguing that such action violates the Administrative Procedure Act. Broad health care transparency and disclosure measures can help facilitate more informed health care decisions for consumers, promote higher value care, and potentially lower health care prices.

Potential Impact:

Robust enforcement of price transparency regulations can promote greater public disclosure and contribute to efforts needed to lower health care costs.